These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 20724485)

  • 1. Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats.
    Banasikowski TJ; Bespalov A; Drescher K; Behl B; Unger L; Haupt A; Schoemaker H; Sullivan JP; Gross G; Beninger RJ
    J Pharmacol Exp Ther; 2010 Nov; 335(2):506-15. PubMed ID: 20724485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse.
    Gyertyán I; Kiss B; Gál K; Laszlovszky I; Horváth A; Gémesi LI; Sághy K; Pásztor G; Zájer M; Kapás M; Csongor EA; Domány G; Tihanyi K; Szombathelyi Z
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1268-78. PubMed ID: 17170312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response.
    Dias FR; Carey RJ; Carrera MP
    Brain Res; 2006 Apr; 1083(1):85-95. PubMed ID: 16530737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
    Banasikowski TJ; Beninger RJ
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nafadotride, CNQX, and haloperidol on acquisition versus expression of amphetamine-conditioned place preference in rats.
    Banasikowski TJ; MacLeod LS; Beninger RJ
    Behav Pharmacol; 2012 Feb; 23(1):89-97. PubMed ID: 22157177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
    Graham DL; Hoppenot R; Hendryx A; Self DW
    Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
    Sautel F; Griffon N; Sokoloff P; Schwartz JC; Launay C; Simon P; Costentin J; Schoenfelder A; Garrido F; Mann A
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1239-46. PubMed ID: 8531087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats.
    Gál K; Gyertyán I
    Drug Alcohol Depend; 2006 Jan; 81(1):63-70. PubMed ID: 16005579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dopamine D3 receptors in controlling the expression of cocaine sensitization in rats.
    Filip M; Papla I; Czepiel K
    Pol J Pharmacol; 2002; 54(6):687-91. PubMed ID: 12866725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
    Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
    Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.
    Martelle JL; Claytor R; Ross JT; Reboussin BA; Newman AH; Nader MA
    J Pharmacol Exp Ther; 2007 May; 321(2):573-82. PubMed ID: 17272677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective antagonist at D3 receptors, but not non-selective partial agonists, influences the expression of cocaine-induced conditioned place preference in free-feeding rats.
    Cervo L; Burbassi S; Colovic M; Caccia S
    Pharmacol Biochem Behav; 2005 Dec; 82(4):727-34. PubMed ID: 16405981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of hemantane on the main subtypes of dopamine receptors in the rat striatum ex vivo].
    Abaimov DA; Zimin IA; Kovalev GI
    Eksp Klin Farmakol; 2008; 71(1):18-21. PubMed ID: 18365481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral interactions produced by co-administration of 7-OH-DPAT with cocaine or apomorphine in the rat.
    Khroyan TV; Fuchs RA; Beck AM; Groff RS; Neisewander JL
    Psychopharmacology (Berl); 1999 Mar; 142(4):383-92. PubMed ID: 10229063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.